CARDINAL HEALTH INC
For the period ended Dec 31, 2024. Filed Jan 30, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Dec 31, 2024 · Filed Jan 30, 2025
CAH$276.79+0.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Financial Statemen
| Three Months Ended December 31, | Six Months Ended December 31, | |||
|---|---|---|---|---|
| (in millions, except per common share amounts) | 2024 | 2023 | 2024 | 2023 |
| Revenue | $55,264 | $57,442 | $107,541 | $112,092 |
| Cost of products sold | 53,323 | 55,588 | 103,698 | 108,495 |
| Gross margin | 1,941 | 1,854 | 3,843 | 3,597 |
| Operating expenses: | ||||
| Distribution, selling, general and administrative expenses | 1,306 | 1,268 | 2,583 | 2,454 |
| Restructuring and employee severance | 9 | 28 | 33 | 53 |
| Amortization and other acquisition-related costs | 105 | 63 | 179 | 127 |
| Impairments and (gain)/loss on disposal of assets, net | 3 | 1 | 2 | 542 |
| Litigation (recoveries)/charges, net | (31) | (11) | (71) | (52) |
| Operating earnings | 549 | 505 | 1,117 | 473 |
| Other (income)/expense, net | 3 | (10) | (2) | (9) |
| Interest expense, net | 35 | 3 | 67 | 14 |
| Earnings before income taxes | 511 | 512 | 1,052 | 468 |
| Provision for income taxes | 110 | 143 | 234 | 110 |
| Net earnings | 401 | 369 | 818 | 358 |
| Less: Net earnings attributable to noncontrolling interests | (1) | (1) | (2) | (2) |
| Net earnings attributable to Cardinal Health, Inc. | $400 | $368 | $816 | $356 |
| Earnings per common share attributable to Cardinal Health, Inc.: | ||||
| Basic | $1.65 | $1.50 | $3.37 | $1.44 |
| Diluted | 1.65 | 1.50 | 3.35 | 1.43 |
| Weighted-average number of common shares outstanding: | ||||
| Basic | 242 | 245 | 242 | 247 |
| Diluted | 243 | 246 | 243 | 248 |
| Cash dividends declared per common share | $0.5056 | $0.5006 | $1.0112 | $1.0012 |
| 21 | Cardinal Health | Q2 Fiscal 2025 Form 10-Q |
Financial Statements
Condensed Consolidated Statements of Comprehensive Income
| Three Months Ended December 31, | Six Months Ended December 31, | |||
|---|---|---|---|---|
| (in millions) | 2024 | 2023 | 2024 | 2023 |
| Net earnings | $401 | $369 | $818 | $358 |
| Other comprehensive income/(loss): | ||||
| Foreign currency translation adjustments and other | (16) | 6 | (11) | (5) |
| Net unrealized gain/(loss) on derivative instruments, net of tax | (9) | 4 | (2) | 1 |
| Total other comprehensive income/(loss), net of tax | (25) | 10 | (13) | (4) |
| Total comprehensive income | 376 | 379 | 805 | 354 |
| Less: comprehensive income attributable to noncontrolling interests | (1) | (1) | (2) | (2) |
| Total comprehensive income attributable to Cardinal Health, Inc. | $375 | $378 | $803 | $352 |
| 22 | Cardinal Health | Q2 Fiscal 2025 Form 10-Q |
Financial Statements
Condensed Consolidated Balance Sheets
| (in millions) | December 31, 2024 | June 30, 2024 |
|---|---|---|
| (Unaudited) | ||
| Assets | ||
| Current assets: | ||
| Cash and equivalents | $3,810 | $5,133 |
| Trade receivables, net | 12,369 | 12,084 |
| Inventories, net | 16,904 | 14,957 |
| Prepaid expenses and other | 2,623 | 2,663 |
| Assets held for sale | 50 | 47 |
| Total current assets | 35,756 | 34,884 |
| Property and equipment, net | 2,558 | 2,529 |
| Goodwill and other intangibles, net | 7,436 | 6,450 |
| Other assets | 1,252 | 1,258 |
| Total assets | $47,002 | $45,121 |
| Liabilities and Shareholders’ Deficit | ||
| Current liabilities: | ||
| Accounts payable | $31,298 | $31,759 |
| Current portion of long-term obligations and other short-term borrowings | 544 | 434 |
| Other accrued liabilities | 3,381 | 3,447 |
| Total current liabilities | 35,223 | 35,640 |
| Long-term obligations, less current portion | 7,062 | 4,658 |
| Deferred income taxes and other liabilities | 7,638 | 8,035 |
| Shareholders’ deficit: | ||
| Preferred shares, without par value: | ||
| Authorized—500 thousand shares, Issued—none | — | — |
| Common shares, without par value: | ||
| Authorized—755 million shares, Issued—271 million shares and 327 million shares at December 31, 2024 and June 30, 2024, respectively | 2,932 | 2,917 |
| Retained earnings/(accumulated deficit) | 283 | (286) |
| Common shares in treasury, at cost: 29 million shares and 83 million shares at December 31, 2024 and June 30, 2024, respectively | (6,026) | (5,677) |
| Accumulated other comprehensive loss | (180) | (167) |
| Total Cardinal Health, Inc. shareholders' deficit | (2,991) | (3,213) |
| Noncontrolling interests | 70 | 1 |
| Total shareholders’ deficit | (2,921) | (3,212) |
| Total liabilities and shareholders’ deficit | $47,002 | $45,121 |
| 23 | Cardinal Health | Q2 Fiscal 2025 Form 10-Q |
Financial Statements
Condensed Consolidated Statements of Shareholders' Deficit
| Common Shares · Retained Earnings/(Accumulated Deficit) · Treasury Shares · Accumulated OtherComprehensiveLoss · Noncontrolling Interests · TotalShareholders’ Deficit | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (in millions) · Shares Issued · Amount · Shares · Amount | |||||||||||||||
| Three Months Ended December 31, 2024 | |||||||||||||||
| Balance at September 30, 2024 | 327 | $2,827 | $14 | (85) | $(5,963) | $(155) | $1 | $(3,276) | |||||||
| Net earnings | 400 | 1 | 401 | ||||||||||||
| Other comprehensive loss, net of tax | (25) | (25) | |||||||||||||
| Acquisitions | 72 | 72 | |||||||||||||
| Employee stock plans activity, net of shares withheld for employee taxes | — | 30 | — | 13 | 43 | ||||||||||
| Share repurchase program activity | — | 75 | — | (76) | (1) | ||||||||||
| Retirement of treasury stock | (56) | — | 56 | — | — | ||||||||||
| Dividends declared | (128) | (128) | |||||||||||||
| Payments to noncontrolling interests | (4) | (4) | |||||||||||||
| Other | — | — | (3) | (3) | |||||||||||
| Balance at December 31, 2024 | 271 | $2,932 | $283 | (29) | $(6,026) | $(180) | $70 | $(2,921) | |||||||
| Three Months Ended December 31, 2023 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance at September 30, 2023 | 327 | $2,728 | $(780) | (80) | $(5,391) | $(165) | $1 | $(3,607) | |||||
| Net earnings | 368 | 1 | 369 | ||||||||||
| Other comprehensive income, net of tax | 10 | 10 | |||||||||||
| Employee stock plans activity, net of shares withheld for employee taxes | — | 27 | — | 31 | 58 | ||||||||
| Share repurchase program activity | — | 100 | (4) | (354) | (254) | ||||||||
| Dividends declared | (123) | (123) | |||||||||||
| Other | 1 | — | — | ||||||||||
| Balance at December 31, 2023 | 327 | $2,855 | $(535) | (83) | $(5,714) | $(155) | $2 | $(3,547) | |||||
| Six Months Ended December 31, 2024 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance at June 30, 2024 | 327 | $2,917 | $(286) | (83) | $(5,677) | $(167) | $1 | $(3,212) | ||||||||
| Net earnings | 816 | 2 | 818 | |||||||||||||
| Other comprehensive loss, net of tax | (13) | (13) | ||||||||||||||
| Acquisitions | 72 | 72 | ||||||||||||||
| Employee stock plans activity, net of shares withheld for employee taxes | — | 15 | 1 | 30 | 45 | |||||||||||
| Share repurchase program activity | (3) | (379) | (379) | |||||||||||||
| Retirement of treasury stock | (56) | — | 56 | — | — | |||||||||||
| Dividends declared | (247) | (247) | ||||||||||||||
| Payments to noncontrolling interests | (4) | (4) | ||||||||||||||
| Other | — | — | (1) | (1) | ||||||||||||
| Balance at December 31, 2024 | 271 | $2,932 | $283 | (29) | $(6,026) | $(180) | $70 | $(2,921) | ||||||||
| Six Months Ended December 31, 2023 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance at June 30, 2023 | 327 | $2,746 | $(642) | (76) | $(4,911) | $(151) | $1 | $(2,957) | |||||
| Net earnings | 356 | 2 | 358 | ||||||||||
| Other comprehensive loss, net of tax | (4) | (4) | |||||||||||
| Employee stock plans activity, net of shares withheld for employee taxes | — | 9 | 1 | 56 | 65 | ||||||||
| Share repurchase program activity | — | 100 | (9) | (859) | (759) | ||||||||
| Dividends declared | (249) | (249) | |||||||||||
| Other | (1) | (1) | |||||||||||
| Balance at December 31, 2023 | 327 | $2,855 | $(535) | (83) | $(5,714) | $(155) | $2 | $(3,547) | |||||
| 24 | Cardinal Health | Q2 Fiscal 2025 Form 10-Q |
Financial Statements
Condensed Consolidated Statements of Cash Flows
| Six Months Ended December 31, | ||
|---|---|---|
| (in millions) | 2024 | 2023 |
| Cash flows from operating activities: | ||
| Net earnings | $818 | $358 |
| Adjustments to reconcile net earnings to net cash provided by operating activities: | ||
| Depreciation and amortization | 374 | 347 |
| Impairments and loss on sale of other investments | 2 | — |
| Impairments and (gain)/loss on disposal of assets, net | 2 | 542 |
| Share-based compensation | 60 | 57 |
| Provision for bad debts | 28 | 21 |
| Change in operating assets and liabilities, net of effects from acquisitions and divestitures: | ||
| Increase in trade receivables | (253) | (480) |
| Increase in inventories | (1,967) | (2,449) |
| Increase/(decrease) in accounts payable | (470) | 4,353 |
| Other accrued liabilities and operating items, net | (641) | (1,042) |
| Net cash provided by/(used in) operating activities | (2,047) | 1,707 |
| Cash flows from investing activities: | ||
| Acquisition of subsidiaries, net of cash acquired | (1,076) | — |
| Proceeds from divestitures, net of cash sold | 2 | 9 |
| Additions to property and equipment | (189) | (206) |
| Proceeds from disposal of property and equipment | — | 2 |
| Purchases of investments | (3) | (2) |
| Proceeds from investments | 2 | 1 |
| Proceeds from net investment hedge terminations | — | 28 |
| Proceeds from short-term investment in time deposit | 200 | — |
| Net cash used in investing activities | (1,064) | (168) |
| Cash flows from financing activities: | ||
| Proceeds from long-term obligations, net of issuance costs | 2,869 | — |
| Reduction of long-term obligations | (423) | (15) |
| Net tax proceeds/(withholding) from share-based compensation | (15) | 1 |
| Dividends on common shares | (250) | (255) |
| Purchase of treasury shares, net | (390) | (750) |
| Net cash provided by/(used in) financing activities | 1,791 | (1,019) |
| Effect of exchange rate changes on cash and equivalents | (3) | 1 |
| Net increase/(decrease) in cash and equivalents | (1,323) | 521 |
| Cash and equivalents at beginning of period | 5,133 | 4,076 |
| Cash and equivalents at end of period | $3,810 | $4,597 |
| 25 | Cardinal Health | Q2 Fiscal 2025 Form 10-Q |
Notes to Financial Statements
Notes to Condensed Consolidated Financial Statements
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.